T. Rowe Price Institutional Mid-Cap Equity Growth Fund
PMEGX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 100 East Pratt Street Baltimore MD United States of America 21202
- IPO Date
- Jul 30, 1996
- CIK
- 0001012968
- Website
- troweprice.com
- Similar Companies
- Business
- T. Rowe Price Institutional Mid-Cap Equity Growth Fund (PMEGX) is an actively managed mutual fund that seeks long-term capital growth by investing primarily in common stocks of mid-cap growth companies, defined as those with market capitalizations between $2 billion and $10 billion at the time of purchase. The fund offers institutional investors exposure to a diversified portfolio of U.S. mid-cap equities exhibiting strong growth characteristics, including high earnings growth potential, innovative business models, and competitive advantages; it employs a bottom-up fundamental analysis approach, focusing on sectors such as technology, healthcare, consumer discretionary, and industrials. PMEGX provides daily liquidity, professional portfolio management by experienced analysts like Taymour Tamaddon, and a low expense ratio relative to peers, catering to institutional clients including retirement plans, endowments, and foundations. Founded as part of T. Rowe Price Group, Inc., established in 1937 and headquartered in Baltimore, Maryland, the fund operates within the broader T. Rowe Price asset management ecosystem, which oversees approximately $1.5 trillion in assets under management globally as of late 2025. T. Rowe Price Group maintains operations across North America, Europe, Asia-Pacific, and Latin America, with key offices in London, Hong Kong, Tokyo, and Sydney, serving a diverse client base of individual, institutional, and intermediary investors. The parent company emphasizes proprietary research, risk management, and long-term investment horizons across equity, fixed income, multi-asset, and alternative strategies. Recent developments include T. Rowe Price's strategic expansion into alternative investments through the 2024 launch of new private credit and infrastructure funds, enhancing its offerings beyond traditional public markets; a key partnership with BlackRock in mid-2025 to integrate ESG analytics into core equity strategies, including mid-cap growth portfolios like PMEGX; and the acquisition of Oak Hill Advisors in early 2025, bolstering capabilities in private markets while maintaining focus on institutional equity solutions. In response to market volatility, the fund underwent a portfolio rebalancing in Q3 2025, increasing allocations to AI-driven technology firms and resilient healthcare innovators. These changes position PMEGX to capitalize on evolving mid-cap growth opportunities amid economic shifts.